Shot in the dark: Early COVID-19 vaccine efficacy explained
Moderna Inc delivered the latest good news from COVID-19 vaccine developers, saying its experimental vaccine is 94.5 per cent effective in preventing the disease based on interim data from a late-stage trial.
Go to Source